lower extremity chronic venous disease

20121

Recommendation

horse chestnut seed extract 300mgescin50mg2

(())

50%

(sequestration)

BMI
or

DVT

Duplex Ultrasound0.5

Air plethysmography

Photoplethysmography
Ankle-brachial index

Pit fall
.
.
.
.

20%

8 10mmHgDVT

Over View

.
.
. : IPCP
. 300mgProstacylin analogues

.
.
.

.
3034

. 97%

. 3
.
. 20%

. 20 30mmHg
8 10mmHgDVT
30 40mmHg
40 50mmHg50 60mmHg

chaps

.
20 30

6
Intermittent Pneumatic Compression Therapy
.

.
. 4
.

20300mg
(38vs0%)
(52%vs26%)

.
.Pentoxifyline
(RR1.7, 95% CI 1.3-2.2)

.Stanozolol

.EscinHCE
300mg2(Escin50mg)

.HydroxyethylrutosideHR
30USA
.Sulodexide
USA

.Prostacylin analogues
iloprost0.5-2mg/min

.
Silver sulfadiazine

Cadexomer iodine

. human skin equivalents

12

(
)

(30%13%silver sulfadiazine)

.
40mmHg
.
vein ablation therapies

Recommendation

tolerated

horse chestnut seed extract 300mgescin50mg2
(Grade2B)

( ( ) )
(Grade2C)

(Grade2B)

UpToDate; Medical management of lower extremity chronic venous disease